A phase II study of Cord blood transplantation for elderly patients with hematologic malignancies using fludarabine and intravenous busulfan.
Phase of Trial: Phase II
Latest Information Update: 22 Mar 2018
At a glance
- Drugs Busulfan (Primary) ; Cord blood stem cell therapy (Primary) ; Fludarabine (Primary) ; Mycophenolate mofetil; Tacrolimus
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 12 Aug 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 06 Apr 2013 New trial record